Intrepid Family Office LLC bought 110,000 HeartFlow shares.
The position value at quarter end was by $2.7 million, reflecting both the share purchase and price movement during the period.
HeartFlow now represents 2.16% of 13F AUM, which places it outside the fund's top five holdings.
According to an SEC filing dated May 15, 2026, institutional investment manager Intrepid Family Office LLC initiated a new position in HeartFlow (NASDAQ:HTFL), acquiring 110,000 shares in the first quarter.
The estimated transaction value is $2.99 million, calculated using the average closing price between January 1 and March 31, 2026. At quarter’s end, the stake was valued at $2.68 million, reflecting both the share purchase and price fluctuations during the period.
| Metric | Value |
|---|---|
| Price (as of market close May 14, 2026) | $32.24 |
| Market capitalization | $2.56 billion |
| Revenue (TTM) | $191.42 million |
| Net income (TTM) | ($111.83 million) |
HeartFlow, Inc. is a healthcare technology company specializing in advanced, non-invasive cardiac diagnostics. Its strategy centers on leveraging artificial intelligence and computational modeling to provide actionable insights for clinicians managing coronary artery disease.
Intrepid Family Office’s first quarter buy of HeartFlow stock is a noteworthy event for investors. It represents the institutional investor’s initial stake, indicating Intrepid Family Office has a bullish outlook towards the company.
HeartFlow went public in August of 2025 but the stock fell to a 52-week low of $20.13 in February, which may have prompted Intrepid Family Office’s Q1 buy. In Q2, shares are up as the company reported first-quarter revenue of $52.6 million, an impressive 41% year-over-year increase. It isn’t a profitable business just yet, but its Q1 net loss of $27.4 million is an improvement over the $32.3 million loss suffered in the prior year.
HeartFlow also sports a solid balance sheet. Its total Q1 assets of $344 million eclipsed total liabilities of $58.3 million. Thanks to the company’s solid performance, its stock’s price-to-sales ratio is at 14, up from five at the end of Q1.
Shares were a better buy in the first quarter, a factor that may have played into Intrepid Family Office’s purchase, but the sales multiple remains lower than the 18 it was at last year. So it may not be a bad time to buy if you believe HeartFlow can continue to produce strong sales growth while reducing its costs to eventually achieve profitability.
Before you buy stock in HeartFlow, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and HeartFlow wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $463,900!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,294,401!*
Now, it’s worth noting Stock Advisor’s total average return is 978% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of May 31, 2026.
Robert Izquierdo has positions in HeartFlow. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.